Nomura Asset Management International’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Nomura Asset Management International's BMY Position: Q2 2026 in Review
Nomura Asset Management International reduced its Bristol-Myers Squibb (BMY) stake by 3.6% in Q2 2026, selling an estimated $3.78M and leaving 1,776,782 shares worth $102M. The position accounts for 0.15% of the portfolio, ranked #143.
Nomura Asset Management International first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $112M in Q1 2026. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Nomura Asset Management International held 1,776,782 shares of Bristol-Myers Squibb worth $102M as of Q2 2026.
- Nomura Asset Management International sold 65,757 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.78M.
- Bristol-Myers Squibb made up 0.15% of Nomura Asset Management International's portfolio in Q2 2026, its #143 holding.
- Nomura Asset Management International first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Nomura Asset Management International's Bristol-Myers Squibb position peaked at $112M in Q1 2026.
- 2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.